Late-breaker abstracts can be submitted in 29 categories of biomedical prevention, including to a new category: “COVID-19 research: Applying .. Read more lessons from HIV prevention to SARS CoV-2.”. The health and safeguarding of our community are our highest priorities. IAS – the International AIDS Society – has decided that, in light of the COVID-19 pandemic, the HIV Research for Prevention Conference (HIVR4P) will be held virtually. HIVR4P fosters interdisciplinary knowledge-exchange on HIV vaccines, microbicides, PrEP, treatment as prevention and biomedical interventions as well as their related social and behavioural implications. The great strength of HIVR4P is the participation of researchers, policy makers, implementers and advocates working across the spectrum of biomedical interventions and scientific disciplines informing state-of-the-art HIV prevention from pre-clinical research through to implementation. The International AIDS Society (IAS) leads collective action on every front of the global HIV response through its membership base, scientific authority and convening power.
- Share your Experience